UPSC MainsMEDICAL-SCIENCE-PAPER-II20175 Marks
Q28.

A 75-year-old male presented with acute retention of urine with haematuria. On per rectal examination, hard nodular prostatic enlargement is present. Discuss the diagnosis and its investigation.

How to Approach

This question requires a systematic approach to diagnosis based on the clinical presentation. The answer should begin by outlining the most likely diagnosis given the symptoms, followed by a detailed investigation plan. Prioritize investigations based on their yield and cost-effectiveness. Mention differential diagnoses briefly. Structure the answer into Introduction, likely diagnosis, investigations (categorized), and a brief discussion of management. Focus on a logical flow of investigations, starting with non-invasive and progressing to more invasive procedures if needed.

Model Answer

0 min read

Introduction

Acute urinary retention (AUR) is the sudden inability to voluntarily void urine. Haematuria, the presence of blood in the urine, alongside AUR, raises concern for underlying urological pathology. In an elderly male, the most common cause of AUR is benign prostatic hyperplasia (BPH), often complicated by bladder outlet obstruction. However, other etiologies must be considered. A per rectal examination revealing a hard, nodular prostate strongly suggests prostatic enlargement, potentially malignant. Prompt and accurate diagnosis is crucial for appropriate management and improved patient outcomes.

Diagnosis

The most likely diagnosis, given the clinical presentation of acute urinary retention, haematuria, and a hard, nodular prostate on per rectal examination, is prostatic enlargement secondary to either Benign Prostatic Hyperplasia (BPH) or Prostate Cancer. The haematuria could be due to vascular congestion within the enlarged prostate, irritation of the bladder mucosa from the catheter, or, more concerningly, a sign of malignancy.

Differential Diagnoses

While BPH or prostate cancer are most probable, other possibilities include:

  • Prostatitis: Inflammation of the prostate, though typically presents with pain and fever.
  • Urethral Stricture: Narrowing of the urethra, less likely given the prostate findings.
  • Bladder Neck Obstruction: Less common in isolation.
  • Neurogenic Bladder: Less likely without a history of neurological disease.

Investigations

Phase 1: Initial Assessment & Basic Investigations

These investigations are aimed at confirming the diagnosis, assessing renal function, and ruling out acute complications.

  • Urinalysis & Microscopy: To confirm haematuria, rule out infection (pyuria), and assess for malignant cells.
  • Serum Creatinine & Electrolytes: To assess renal function, which may be impaired due to post-renal acute kidney injury.
  • Prostate-Specific Antigen (PSA): A crucial marker for prostate cancer. Elevated levels warrant further investigation.
  • Complete Blood Count (CBC): To assess for anaemia (due to chronic blood loss) and signs of infection.
  • Post-Void Residual (PVR) Volume: Measured via ultrasound. Although the patient has acute retention, this is useful post-catheterization to assess bladder emptying.

Phase 2: Imaging & Further Evaluation

These investigations help to characterize the prostate and rule out other causes of haematuria.

  • Transrectal Ultrasound (TRUS): Provides detailed images of the prostate, including size, shape, and echogenicity. Can guide prostate biopsies.
  • Multiparametric MRI (mpMRI) of the Prostate: Increasingly used as a first-line imaging modality for suspected prostate cancer. Provides functional information about the prostate, improving diagnostic accuracy.
  • Cystoscopy: Allows direct visualization of the urethra and bladder neck, assessing for obstruction, inflammation, or tumours.
  • Upper Tract Imaging (CT Urographram or Renal Ultrasound): To rule out upper tract obstruction or other causes of haematuria (e.g., renal cell carcinoma).

Phase 3: Biopsy & Histopathology

If malignancy is suspected based on PSA levels, imaging findings, or clinical suspicion, a biopsy is necessary.

  • Prostate Biopsy: Typically performed transrectally under ultrasound guidance. Multiple cores are taken from different areas of the prostate.
  • Histopathological Examination: Biopsy samples are examined under a microscope to determine the presence and grade of cancer.
Investigation Purpose Advantages Disadvantages
PSA Screening for prostate cancer Relatively inexpensive, widely available Can be elevated in BPH and prostatitis; not specific for cancer
TRUS Prostate imaging, biopsy guidance Real-time imaging, allows for targeted biopsy Can be uncomfortable, risk of infection
mpMRI Prostate imaging, cancer detection High sensitivity and specificity for cancer detection More expensive than TRUS, availability may be limited

Conclusion

In conclusion, a 75-year-old male presenting with acute urinary retention and haematuria with a hard, nodular prostate on PR examination necessitates a thorough investigation to differentiate between BPH and prostate cancer. A stepwise approach, starting with basic investigations and progressing to imaging and biopsy as indicated, is crucial. Prompt diagnosis and appropriate management are essential to alleviate symptoms, prevent complications, and improve the patient’s quality of life. The presence of haematuria warrants a high index of suspicion for malignancy.

Answer Length

This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.

Additional Resources

Key Definitions

Benign Prostatic Hyperplasia (BPH)
Non-cancerous enlargement of the prostate gland, common in aging men, leading to urinary symptoms.
Haematuria
The presence of blood in the urine. It can be macroscopic (visible to the naked eye) or microscopic (detectable only under a microscope).

Key Statistics

Prostate cancer is the most commonly diagnosed cancer in men globally, with an estimated 1.4 million new cases in 2020.

Source: World Health Organization (WHO), 2020

The incidence of BPH increases with age, affecting over 50% of men aged 60 years and older.

Source: American Urological Association (AUA), Knowledge cutoff 2023

Examples

Case of Prostate Cancer Detection

A 70-year-old male presented with similar symptoms. Initial PSA was elevated at 8 ng/mL. mpMRI revealed a suspicious lesion in the prostate. Biopsy confirmed adenocarcinoma of the prostate (Gleason score 7). He underwent radical prostatectomy and is currently disease-free.

Frequently Asked Questions

Is a high PSA always indicative of prostate cancer?

No, a high PSA can be caused by several factors, including BPH, prostatitis, recent ejaculation, and age. Further investigations are needed to determine the cause.

Topics Covered

MedicineUrologyProstateUrinary RetentionDiagnosis